Interim analysis of 1-level BAGUERA®C IDE study meets threshold for non-inferiorityGeneva, March 11, 2025 – Spineart, a fast-growing company in ...
Interim data on Spineart’s Baguera-C cervical disc shows the device meets the threshold for a non-inferiority claim compared to a study control, the medtech company said March 11. Spineart plans to ...
Here are six key updates from spine and orthopedic companies since March 5. 1. Aurora Spine completed enrollment for its Refine study on lumbar interlaminar fusion. 2. Interim data on Spineart’s ...
Geneva, March 11, 2025 – Spineart, a fast-growing company in spine surgery innovation, today announces that it has completed a planned interim analysis for its 1-level BAGUERA®C IDE study ...
Geneva, March 11, 2025 - Spineart, a fast-growing company in spine surgery innovation, today announces that it has completed a planned interim analysis for its 1-level BAGUERA®C IDE study, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results